洛拉泽帕姆的不良事件概况:使用FDA不良事件报告系统数据库进行现实世界药监测研究
Zhengkang Su1, Zhengwei Huang1, Xiaoyu Chen1,2
1The Affiliated Kangning Hospital of Wenzhou Medical University, Zhejiang Provincial Clinical Research Center for Mental Health, Wenzhou, Zhejiang, China.
洛拉泽用于焦虑和失眠,可能会带来危险,包括药物滥用,心脏问题和免疫抑制. 这项研究强调了潜在的不良事件,以指导更安全的临床使用.
科学领域:
- 药物监督 药物监督 药物监督
- 临床安全 临床安全
- 数据挖掘 数据挖掘
背景情况:
- 在COVID-19大流行后,焦虑诊断的增加.
- 洛拉泽是一种常见的治疗焦虑和失眠.
- 洛拉泽的长期安全数据有限.
研究的目的:
- 评估与洛拉泽相关的不良事件 (AE).
- 使用美国FDA的不良事件报告系统 (FAERS).
- 告知未来的治疗实践,为lorazepam.
主要方法:
- 在FAERS数据库中进行数据挖掘.
- 对报告的洛拉泽相关不良事件的分析.
- 识别流行和新出现的安全信号.
主要成果:
- 流行性AE包括药物滥用,自杀企图,昏昏欲睡,妄想和精神障碍.
- 发现了新的安全信号:脂肪代谢异常,心脏功能障碍和与免疫抑制有关的疾病.
- 扩大对洛拉泽帕姆安全性概况的理解.
结论:
- 洛拉泽的使用与常见副作用以外的重大不良事件有关.
- 这些发现为lorazepam的合理和更安全的临床应用提供了指导.
- 对洛拉泽帕姆的长期安全性进行进一步研究是有必要的.
更多相关视频
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Regulation
